Assessing the Awareness of Prediabetes and Its Risk Factors among medical students
DOI:
https://doi.org/10.63666/ejsmr.1694-9013.1.I.2025.20Keywords:
Prediabetes, Hypertension, medical students, JASUAbstract
Introduction: Prediabetes is a condition where blood glucose levels are elevated but not yet high enough to be classified as diabetes. It is typically identified through impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), with specific blood sugar thresholds.
Methodology: A cross-sectional study was conducted between October 29 and November 26, 2024, involving medical students from the 2nd to 5th years. Data was gathered through a semi-structured questionnaire distributed via Google Forms. Statistical analysis was performed using SPSS software, and the results were expressed in percentages.
Results: Among the 213 respondents, the majority were in their 2nd year (42.7%) and aged between 20-25 years (61.5%), with a slightly higher proportion of males (53.1%). Most respondents were Muslim (53.1%) and from India (69%). While many students were aware of prediabetes (168 participants), only 53 had attended extra classes on the topic. Knowledge of prediabetes improved as students advanced in their studies. Fifth-year students demonstrated the best understanding of key topics, such as HbA1c levels (66.7%) and prediabetes complications (89.9%). Second-year students had a solid grasp of prediabetes, while third-year students showed relatively less knowledge.
Conclusion: This study reveals that medical students possess general knowledge about prediabetes, its risk factors, and symptoms, but there are areas that require improvement. Although many students were familiar with the definition of prediabetes, few had participated in additional educational sessions on the subject. Awareness of risk factors, such as gestational diabetes, was moderate, and some students were unaware that prediabetes can be asymptomatic. Clinical knowledge tended to improve with academic progression, with older students exhibiting a stronger understanding of diagnostic criteria and complications. Younger students, particularly those in the second and third years, had less comprehensive knowledge. These results emphasize the need for enhanced education, especially for students in the earlier years of their medical studies.
References
1. Muthunarayanan L, Ramraj B, Russel JK. Prevalence of prediabetes and its associated risk factors among rural adults in Tamil Nadu. Arch Med Health Sci. 2015;3(2):178-184.
2. Care D. Care in diabetes—2022. Diabetes Care. 2022 Jan 1;45:S17.
3. Rooney MR, Fang M, Ogurtsova K, et al. Global prevalence of prediabetes. Diabetes Care. 2023 Jul 1;46(7):1388-1394.
4. Tandon N, Mohan V. ICMR guidelines for management of type 2 diabetes. 2018.
5. Centers for Disease Control and Prevention. Available from: https://www.cdc.gov/diabetes/php/data-research/index.html.
6. Lawal Y, Bello F, Kaoje YS. Prediabetes deserves more attention: a review. Clin Diabetes. 2020 Oct 1;38(4):328-338.
7. Abdul-Ghani MA, DeFronzo RA. Pathophysiology of prediabetes. Curr Diabetes Rep. 2009 Jun;9(3):193-199.
8. Bacha F, Hannon TS, Tosur M, et al. Pathophysiology and treatment of prediabetes and type 2 diabetes in youth. Diabetes Care. 2024 Dec 1;47(12):2038-2049.
9. Brannick B, Dagogo-Jack S. Prediabetes and cardiovascular disease: pathophysiology and interventions for prevention and risk reduction. Endocrinol Metab Clin North Am. 2018 Mar 1;47(1):33-50.
10. Alvarez S, Coffey R, Algotar AM. Prediabetes.
11. Kanat M, DeFronzo RA, Abdul-Ghani MA. Treatment of prediabetes. World J Diabetes. 2015 Sep 9;6(12):1207.
12. Mulla IG, Anjankar A, Pratinidhi S, et al. Prediabetes: a benign intermediate stage or a risk factor in itself? Cureus. 2024 Jun 26;16(6):e63186.
13. Zand A, Ibrahim K, Patham B. Prediabetes: why should we care? Methodist Debakey Cardiovasc J. 2018 Oct;14(4):289-294.
14. Galaviz KI, Suvada K, Merchant R, et al. Interventions for reversing prediabetes: a systematic review and meta-analysis. Am J Prev Med. 2022 Apr 1;62(4):614-625.
15. Magge SN, Silverstein J, Elder D, et al. Evaluation and treatment of prediabetes in youth. J Pediatr. 2020 Apr 1;219:11-22.
16. Ping WX, Hu S, Su JQ, Ouyang SY. Metabolic disorders in prediabetes: from mechanisms to therapeutic management. World J Diabetes. 2024 Mar 3;15(3):361.
17. Saeed N, Jaffery T, Ansari FA, et al. Knowledge and perceptions about pre-diabetes amongst doctors, medical students, and patients in a tertiary care hospital of Islamabad. J Pak Med Assoc. 2019 Apr 1;69(4):527-532.
18. Liu C, Foti K, Grams ME, et al. Trends in self-reported prediabetes and metformin use in the USA: NHANES 2005-2014. J Gen Intern Med. 2020 Jan;35:95-101.
19. Moin T, Li J, Duru OK, et al. Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study. Ann Intern Med. 2015 Apr 21;162(8):542-548.
20. Katon JG, Reiber GE, Nelson KM. Peripheral neuropathy defined by monofilament insensitivity and diabetes status: NHANES 1999-2004. Diabetes Care. 2013 Jun 1;36(6):1604-1606.
21. Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent‐onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007 Feb;24(2):137-144.
22. Plantinga LC, Crews DC, Coresh J, et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010 Apr 1;5(4):673-682.
23. American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017 Jan 1;40(Supplement_1):S11-S24.
24. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393-403.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Eurasian Journal of Scientific and Multidisciplinary Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
